![Neil Gibson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Gibson
Directeur/Membre du Conseil chez
INSTIL BIO, INC.
Fortune : 313 833 $ au 31/05/2026
Profil
Neil W.
Gibson currently serves as Independent Director at Shattuck Labs, Inc. since 2016, Lead Independent Director at Instil Bio, Inc. since 2021, Director at Cullinan MICA, Inc. since 2020, and Director at both Causeway Therapeutics Ltd. and Cullinan Mica Corp.
Former roles include President & Chief Executive Officer at Cullinan Mica Corp.
from 2017 to 2020, President & Co-Chief Executive Officer at Adanate, Inc. from 2017 to 2021, Independent Director at TCR² Therapeutics, Inc. from 2018 to 2023, Director at CytoSen Therapeutics, Inc. from 2016 to 2019, Chief Scientific Officer & Vice President at OSI Pharmaceuticals, Inc. from 2001 to 2007, Chief Scientific Officer-Oncology Research Unit at Pfizer Inc. from 2007 to 2011, Chief Scientific Officer at Regulus Therapeutics, Inc. from 2011 to 2015, Chief Development Officer & Senior Vice President at BioAtla, Inc. from 2015 to 2016, Chief Scientific Officer & Senior Vice President at COI Pharmaceuticals, Inc. from 2016 to 2021, Director-Cancer Research at Bayer AG in 2001, Associate Professor at the University of Southern California, Chief Scientific Officer at Silarus Therapeutics, Inc., President of the British Pharmaceutical Students Association, and President of the British Pharmaceutical Students Association.
Education includes undergraduate studies at the University of Strathclyde and a doctorate from the University of Aston conferred in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SHATTUCK LABS, INC. 0,07 % | 29/05/2026 | 52 745 ( 0,07 % ) | 313 833 $ | 31/05/2026 |
INSTIL BIO, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Neil Gibson
| Sociétés | Poste | Début |
|---|---|---|
| SHATTUCK LABS, INC. | Directeur/Membre du Conseil | 01/11/2016 |
| INSTIL BIO, INC. | Directeur/Membre du Conseil | 01/06/2020 |
Cullinan MICA, Inc.
 Cullinan MICA, Inc. Investment ManagersFinance Provides asset management services | Directeur/Membre du Conseil | 01/01/2020 |
Causeway Therapeutics Ltd.
 Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases | Directeur/Membre du Conseil | - |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Develops immuno-oncology therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Neil Gibson
| Sociétés | Poste | Fin |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/06/2023 |
COI Pharmaceuticals, Inc.
 COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Directeur Technique/Scientifique/R&D | 01/12/2021 |
Adanate, Inc.
 Adanate, Inc. BiotechnologyHealth Technology Develops antibody therapeutics | Directeur Général | 02/11/2021 |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Develops immuno-oncology therapeutics | Directeur Général | 01/06/2020 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Neil Gibson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
BioAtla, Inc.
 BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Health Technology |
Silarus Therapeutics, Inc.
 Silarus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders | Health Technology |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
CytoSen Therapeutics, Inc.
 CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops nanoparticle-based technology and therapeutics | Commercial Services |
Adanate, Inc.
Adanate, Inc. BiotechnologyHealth Technology Develops antibody therapeutics | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Cullinan MICA, Inc.
Cullinan MICA, Inc. Investment ManagersFinance Provides asset management services | Finance |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases | Health Technology |
British Pharmaceutical Students Association |
